Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12485594rdf:typepubmed:Citationlld:pubmed
pubmed-article:12485594lifeskim:mentionsumls-concept:C0043393lld:lifeskim
pubmed-article:12485594lifeskim:mentionsumls-concept:C0080194lld:lifeskim
pubmed-article:12485594lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:12485594lifeskim:mentionsumls-concept:C0301630lld:lifeskim
pubmed-article:12485594pubmed:issue5lld:pubmed
pubmed-article:12485594pubmed:dateCreated2002-12-17lld:pubmed
pubmed-article:12485594pubmed:abstractTextThe stereocontrolled reduction of 3-aryl-5-acetylisoxazolines (1) to the corresponding alcohols (2 and 3) in the presence of four different yeast strains, recognized as Baker's yeast (commercial), Candida krusei (ATCC 14243), Pichia farinosa (NRRL Y110) and Sacchromyces sp. (soil isolate) have been attempted. The C. krusei was found to be diastereoselective for the (R)-1 while the Sacchromyces sp. led to complete reduction to yield the RS- and SS-alcohol in 1:1 ratio at 10 g/L scale.lld:pubmed
pubmed-article:12485594pubmed:languageenglld:pubmed
pubmed-article:12485594pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12485594pubmed:citationSubsetIMlld:pubmed
pubmed-article:12485594pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12485594pubmed:statusMEDLINElld:pubmed
pubmed-article:12485594pubmed:monthOctlld:pubmed
pubmed-article:12485594pubmed:issn0045-2068lld:pubmed
pubmed-article:12485594pubmed:authorpubmed-author:BatraSSlld:pubmed
pubmed-article:12485594pubmed:authorpubmed-author:BhaduriA PAPlld:pubmed
pubmed-article:12485594pubmed:authorpubmed-author:RoeAAlld:pubmed
pubmed-article:12485594pubmed:authorpubmed-author:RoyP KPKlld:pubmed
pubmed-article:12485594pubmed:authorpubmed-author:PatraAAlld:pubmed
pubmed-article:12485594pubmed:authorpubmed-author:TripathiM KMKlld:pubmed
pubmed-article:12485594pubmed:authorpubmed-author:JinwalU KUKlld:pubmed
pubmed-article:12485594pubmed:issnTypePrintlld:pubmed
pubmed-article:12485594pubmed:volume30lld:pubmed
pubmed-article:12485594pubmed:ownerNLMlld:pubmed
pubmed-article:12485594pubmed:authorsCompleteYlld:pubmed
pubmed-article:12485594pubmed:pagination350-5lld:pubmed
pubmed-article:12485594pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:12485594pubmed:meshHeadingpubmed-meshheading:12485594...lld:pubmed
pubmed-article:12485594pubmed:meshHeadingpubmed-meshheading:12485594...lld:pubmed
pubmed-article:12485594pubmed:meshHeadingpubmed-meshheading:12485594...lld:pubmed
pubmed-article:12485594pubmed:meshHeadingpubmed-meshheading:12485594...lld:pubmed
pubmed-article:12485594pubmed:meshHeadingpubmed-meshheading:12485594...lld:pubmed
pubmed-article:12485594pubmed:meshHeadingpubmed-meshheading:12485594...lld:pubmed
pubmed-article:12485594pubmed:year2002lld:pubmed
pubmed-article:12485594pubmed:articleTitleEffect of different strains of yeast on stereocontrolled reduction of 5-acetylisoxazolines.lld:pubmed
pubmed-article:12485594pubmed:affiliationFermentation Technology Division, Central Drug Research Institute, P.O. Box-173, Lucknow 226 001, India.lld:pubmed
pubmed-article:12485594pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12485594pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed